Search Results 941-950 of 17070 for Cell nucleus
GATE1: A Multicenter Phase II Study Of Pirtobrutinib, Rituximab And Venetoclax Combination Therapy For Patients With Previously Untreated Mantle Cell Lymphoma.
Rochester, Minn. The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and ...
Mayo Clinic researchers report finding a new technique to tag senescent cells. ... Biotherapeutics. Science Saturday: A discovery step toward cell replacement ...
D. September 17, 2024. More Mayo neuroscience: Brain cells 'crosstalk' and cancer growth; ...
Leonard Petrucelli, Ph.D., studies the cellular mechanisms underlying neurodegenerative diseases such as Alzheimer's disease, frontotemporal dementia, ...
Durvalumab is FDA approved for treatment in lung cancers including non-small cell lung cancer and small cell lung cancer. Venetoclax is FDA approved for the ...
Pediatric brain tumors include medulloblastoma, glioma, embryonal tumor, germ cell brain tumor, spinal cord tumor, craniopharyngioma and pineoblastoma.
... cell carcinoma, Basal cell carcinoma, Dermatofibrosarcoma protuberans, Gorlin syndrome, Epidermoid cyst, Mole. Show more areas of focus for Ramin Fathi ...
Researchers at Mayo Clinic are developing a Biobank of adult stem cell-rich breast organoids, a new research resource to facilitate normal and cancer stem cell ...
Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.